DLH Holdings Corp. Stock

Equities

DLHC

US23335Q1004

Healthcare Facilities & Services

Market Closed - Nasdaq 04:00:00 2024-04-24 pm EDT 5-day change 1st Jan Change
10.89 USD +0.18% Intraday chart for DLH Holdings Corp. -2.07% -30.86%
Sales 2024 * 404M Sales 2025 * 440M Capitalization 155M
Net income 2024 * 8M Net income 2025 * 14M EV / Sales 2024 * 0.38 x
Net cash position 2024 * - Net cash position 2025 * - EV / Sales 2025 * 0.35 x
P/E ratio 2024 *
19.8 x
P/E ratio 2025 *
11.5 x
Employees 3,200
Yield 2024 *
-
Yield 2025 *
-
Free-Float 86.16%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.18%
1 week-4.22%
Current month-17.94%
1 month-24.22%
3 months-32.49%
6 months-17.06%
Current year-30.86%
More quotes
1 week
10.71
Extreme 10.71
11.47
1 month
10.71
Extreme 10.71
14.44
Current year
10.71
Extreme 10.71
17.58
1 year
9.01
Extreme 9.0101
17.58
3 years
9.01
Extreme 9.0101
21.49
5 years
3.00
Extreme 3
21.49
10 years
1.28
Extreme 1.281
21.49
More quotes
Managers TitleAgeSince
Chief Executive Officer 66 10-02-21
Director of Finance/CFO 64 12-06-24
Chief Tech/Sci/R&D Officer - -
Members of the board TitleAgeSince
Chairman 69 07-01-18
Chief Executive Officer 66 10-02-21
Director/Board Member 81 98-06-30
More insiders
Date Price Change Volume
24-04-24 10.89 +0.18% 19,238
24-04-23 10.87 -2.07% 19,615
24-04-22 11.1 -1.51% 94,436
24-04-19 11.27 +2.08% 32,123
24-04-18 11.04 -0.72% 36,500

Delayed Quote Nasdaq, April 24, 2024 at 04:00 pm EDT

More quotes
DLH Holdings Corp. is a provider of science research and development, systems engineering and integration, and digital transformation and cyber security solutions to federal agencies. The Company is focused on improved deployment of health and defense initiatives for multiple agencies within the federal government, including the Department of Health and Human Services and Department of Defense. Its digital transformation and cyber security solutions include tools, such as artificial intelligence and machine learning, cloud enablement, cybersecurity ecosystem, big data analytics, and modeling and simulation. The Company's science research and development solutions include data analytics, testing and evaluation, clinical trials research services, and epidemiology studies. Its systems engineering and integration solutions include system modernization, enterprise-edge information technology (IT) management, health IT systems, performance-based logistics and robotics and unmanned systems.
Calendar
More about the company
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
10.87 USD
Average target price
21 USD
Spread / Average Target
+93.19%
Consensus